𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration

✍ Scribed by Moustapha Hassan; Zuzana Hassan; Christina Nilsson; Mohamed Abdel Rehim; Susanne Kumlien; Birgitta Elfsson; Nils Kållberg


Publisher
Springer
Year
1998
Tongue
English
Weight
225 KB
Volume
42
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pharmacokinetics and tissue distribution
✍ Xiao Wei Teng; Neal M. Davies; Chie Fukuda; Renee L. Good; Marc W. Fariss 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract Unlike __d__‐alpha tocopherol (T), __d__‐alpha tocopheryl succinate (TS) has the unique ability to selectively kill tumor cells while protecting normal tissue from toxic oxidative stress. The pharmacokinetics of TS and the serum and tissue disposition of TS were studied in male Sprague‐

Pharmacokinetics and tissue distribution
✍ So H. Kim; Jong W. Kwon; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

The pharmacokinetic parameters including tissue distribution and/or biliary excretion of DA-1131, a new carbapenem, were evaluated after intravenous (iv) administration to mice, rats, rabbits, and dogs. After i.v. administration to mice (20, 50, 100, and 200 mg kg-1), rats (50, 100, 200, and 500 mg

PHARMACOKINETICS OF THE ENANTIOMERS OF V
✍ M. MASOOD BHATTI; ROBERT T. FOSTER 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Verapamil is a chiral calcium channel blocking drug which is useful clinically as the racemate in treating hypertension and arrhythmia. The published pharmacokinetic data for verapamil enantiomers in the rat model are limited. Utilizing a stereospeci®c highperformance liquid chromatographic (HPLC) a

Pharmacokinetics of a new reversible pro
✍ Kye S. Han; Yoon G. Kim; Joong K. Yoo; Jong W. Lee; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

The pharmacokinetics of YH1885 were evaluated after intravenous (iv) and oral administrations of the drug to rats and dogs. The reason for the low extent of bioavailability (F) of YH1885 after oral administration of the drug to rats and the absorption of the drug from various rat gastrointestinal (G